WuXi AppTec Co., Ltd. Class H (2359) AI Stock Analysis

• Market Cap: HK$320.62B
• Dividend Yield: 0.33%
• Average Volume (3M): 11.36M
• Price to Earnings (P/E): 21.4
• Beta (1Y): 1.50
• Revenue Growth: 6.94%
• EPS Growth: 43.66%
• Country: HK
• Employees: 39,414
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 1.87
• Shares Outstanding: 478,226,500
• 10 Day Avg. Volume: 9,513,944
• 30 Day Avg. Volume: 11,363,970
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$136.05
• Price Target Upside: 19.76% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 4

• Rating: 79 Outperform
• Price Target: HK$133.00 ▲(17.08% Upside)

WuXi AppTec Co., Ltd. Class H demonstrates strong financial performance and positive technical indicators, contributing significantly to the overall score. The raised guidance and strong earnings call further bolster confidence in the company's future prospects. Valuation is fair, though the low dividend yield may be a drawback for some investors.

WuXi AppTec Co., Ltd. Class H Business Overview & Revenue Model

Company Description

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

How the Company Makes Money

WuXi AppTec generates revenue through a diversified business model that includes service fees for its drug discovery, development, and manufacturing services. Key revenue streams include laboratory testing services, preclinical and clinical trial management, and contract manufacturing for drug products. The company has established significant partnerships with major pharmaceutical firms, biotechnology companies, and academic institutions, which contribute to recurring revenue through long-term contracts and collaborations. Additionally, WuXi AppTec benefits from the growing demand for outsourced services in the pharmaceutical industry, driven by the need for cost-effective and efficient drug development processes.

WuXi AppTec Co., Ltd. Class H Financial Statement Overview

Summary

WuXi AppTec Co., Ltd. Class H shows strong financial performance with high profitability margins and a solid balance sheet. The company has a healthy gross profit margin of 43.77% and a net profit margin of 32.18%. The balance sheet is stable with a low debt-to-equity ratio of 0.12 and a strong ROE of 23.34%. Cash flow metrics are robust, though there is room for improvement in cash conversion.

Income Statement

WuXi AppTec Co., Ltd. Class H has demonstrated strong financial performance with consistent revenue growth and robust profitability metrics. The TTM (Trailing-Twelve-Months) data shows a healthy gross profit margin of 43.77% and a net profit margin of 32.18%, indicating efficient cost management and strong bottom-line performance. The EBIT and EBITDA margins are also impressive at 38.70% and 40.60% respectively, reflecting operational efficiency. The revenue growth rate of 4.61% in the TTM period suggests steady expansion, although it is slightly lower compared to previous years.

Balance Sheet

The company's balance sheet is solid with a low debt-to-equity ratio of 0.12, indicating conservative leverage and financial stability. The return on equity (ROE) is strong at 23.34%, showcasing effective use of shareholder funds to generate profits. The equity ratio stands at 71.47%, reflecting a strong equity base relative to total assets. Overall, the balance sheet reflects a stable financial position with manageable debt levels and strong equity.

Cash Flow

WuXi AppTec Co., Ltd. Class H exhibits healthy cash flow metrics with a free cash flow growth rate of 9.12% in the TTM period, indicating improved cash generation capabilities. The operating cash flow to net income ratio is 0.72, suggesting good cash conversion from earnings. The free cash flow to net income ratio of 0.69 further supports the company's ability to generate cash relative to its net income. The cash flow position is strong, although there is room for improvement in converting operating cash flow into free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	42.80B	39.24B	40.34B	39.35B	22.90B	16.54B
Gross Profit	18.74B	16.28B	16.57B	14.68B	8.31B	6.28B
EBITDA	17.74B	14.54B	14.17B	12.42B	7.37B	4.51B
Net Income	13.77B	9.45B	9.61B	8.81B	5.10B	2.96B
Balance Sheet
Total Assets	83.82B	80.33B	73.67B	64.69B	55.13B	46.29B
Cash, Cash Equivalents and Short-Term Investments	24.43B	19.56B	14.56B	7.99B	8.77B	14.85B
Total Debt	7.29B	4.75B	5.45B	5.87B	4.28B	4.29B
Total Liabilities	23.41B	21.24B	18.15B	17.76B	16.37B	13.57B
Stockholders Equity	59.91B	58.63B	55.12B	46.59B	38.49B	32.49B
Cash Flow
Free Cash Flow	10.28B	8.40B	7.87B	650.34M	-2.35B	942.69M
Operating Cash Flow	14.87B	12.41B	13.39B	10.62B	4.59B	3.97B
Investing Cash Flow	-1.73B	-5.52B	-7.56B	-9.69B	-4.84B	-8.78B
Financing Cash Flow	-5.30B	-3.83B	-3.94B	-1.28B	-1.72B	9.89B

WuXi AppTec Co., Ltd. Class H Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 113.60
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2359, the sentiment is Positive. The current price of 113.6 is above the 20-day moving average (MA) of 106.65, above the 50-day MA of 97.82, and above the 200-day MA of 69.07, indicating a bullish trend. The MACD of 4.28 indicates Negative momentum. The RSI at 60.41 is Neutral, neither overbought nor oversold. The STOCH value of 68.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2359.

WuXi AppTec Co., Ltd. Class H Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2359	79 Outperform	HK$320.62B	21.39	26.41%	0.33%	6.94%	43.66%
Sector *	51 Neutral	$7.92B	-0.43	-41.67%	2.21%	22.29%	-1.85%
WXIBF	―	$18.42B	32.84	9.79%	―	―	―
5HZ1	―	€5.77B	122.62	1.40%	―	―	―
17Q1	―	€5.87B	23.59	10.44%	―	―	―
3692	73 Outperform	HK$214.96B	40.89	16.09%	0.90%	8.68%	0.82%
2268	67 Neutral	HK$76.09B	52.96	19.62%	―	―	―

WuXi AppTec Co., Ltd. Class H Corporate Events

WuXi AppTec Completes HK$7.65 Billion H Share Placement to Fuel Global Expansion

WuXi AppTec Co., Ltd. announced the successful completion of placing 73,800,000 new H shares under a General Mandate, raising net proceeds of HK$7.65 billion. The funds will primarily be used to accelerate global expansion and capacity construction, with a smaller portion allocated for general corporate purposes, reflecting the company’s strategic focus on growth and strengthening its market position.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces Board Composition and Committee Structures

WuXi AppTec Co., Ltd. has announced the composition of its board of directors and their respective roles, highlighting a diverse mix of executive, non-executive, and independent directors. The announcement also details the structure of four key board committees, indicating a strategic focus on audit, remuneration, strategy, and nomination, which may enhance corporate governance and operational efficiency.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces New H Shares Placement Under General Mandate

WuXi AppTec Co., Ltd. has announced a placing agreement to issue 73,800,000 new H shares, representing a significant percentage of its existing issued shares. This move is aimed at raising capital through professional, institutional, and other independent investors, and the shares will be issued under a general mandate without requiring further shareholder approval. The completion of the placing is contingent upon certain conditions and the rights of the placing agents, and there is no guarantee that it will proceed as planned.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$50.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Adjusts Share Repurchase Price Limit Amid Rising Share Value

WuXi AppTec Co., Ltd. has announced an adjustment to the upper limit of the price for its 2025 First Share Repurchase Plan. The company has decided to increase the upper limit to RMB114.15 per share, reflecting confidence in its future development and the value of its shares. This adjustment comes in response to the rising price of the company’s A Shares, ensuring the smooth implementation of the repurchase plan. As of July 28, 2025, WuXi AppTec has repurchased 6,514,425 A Shares, utilizing approximately RMB497 million.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces Key Leadership Changes in Governance Roles

WuXi AppTec Co., Ltd. announced significant changes in its company secretary and authorized representatives. Mr. Yuanzhou Zhang has resigned from his roles, and Ms. Min Han has been appointed to replace him, effective July 28, 2025. Ms. Han brings over a decade of experience in financial institutions and corporate governance. Additionally, Ms. Christine Shaohua Lu-Wong will replace Mr. Edward Hu as an authorized representative following his retirement on July 31, 2025. These changes are expected to strengthen the company’s governance and operational efficiency.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Reports Robust Financial Growth in H1 2025

WuXi AppTec Co., Ltd. announced its unaudited interim results for the first half of 2025, showcasing significant financial growth. The company reported a 20.6% increase in revenue and a 95.5% rise in net profit attributable to owners compared to the previous year. The gross profit margin also improved to 43.8%. Additionally, the Board declared a mid-year dividend, reflecting the company’s strong performance and commitment to returning value to shareholders.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces 2025 Mid-Year Dividend Distribution

WuXi AppTec Co., Ltd. has announced the approval and declaration of a mid-year dividend distribution for 2025, following authorization from shareholders at the 2024 AGM. The dividend amounts to RMB3.5000 per 10 shares, with a total distribution of RMB1,003,083,788.00, subject to adjustments based on share capital changes. This dividend distribution reflects the company’s commitment to returning value to its shareholders and may influence its market positioning by enhancing investor confidence.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces 2025 Mid-Year Dividend Distribution

WuXi AppTec Co., Ltd. has announced the payment of its 2025 mid-year dividend distribution, declaring an interim ordinary dividend of RMB 3.5 per 10 shares for the financial year ending December 31, 2025. The dividend will be paid in Hong Kong dollars at a rate of HKD 3.8463 per 10 shares, with the ex-dividend date set for September 8, 2025, and payment scheduled for September 26, 2025. The company will withhold and pay income taxes on behalf of non-resident enterprise shareholders and investors from various stock exchanges, with tax rates varying between 10% and 20%. This announcement reflects WuXi AppTec’s ongoing commitment to shareholder returns and may impact investor sentiment and market positioning.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Schedules Board Meeting to Review Interim Results

WuXi AppTec Co., Ltd. has announced that its board of directors will meet on July 28, 2025, to review and approve the unaudited interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Projects Significant Profit Growth for H1 2025

WuXi AppTec Co., Ltd. has issued a positive profit alert, anticipating a significant increase in revenue and net profit for the first half of 2025 compared to the same period in 2024. The company expects a revenue of approximately RMB20,799.28 million, marking a 20.64% year-over-year increase, and a net profit attributable to owners of approximately RMB8,560.88 million, a 101.92% increase, driven by operational efficiencies and a gain from the sale of shares in an associate.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$71.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Completes HK$1 Billion H Share Acquisition for Employee Incentive Scheme

WuXi AppTec Co., Ltd. has announced the completion of its acquisition of H Shares worth HK$1 billion under the 2025 H Share Award and Trust Scheme. This acquisition is part of a broader strategy to incentivize core employees by using these shares as award shares, contingent upon the company achieving a revenue target of RMB43 billion for 2025. The scheme aims to align employee interests with company performance without diluting existing shareholder interests, although there remains uncertainty about meeting the revenue conditions.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$70.40 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Completes 2025 Second Share Repurchase Plan

WuXi AppTec Co., Ltd. announced the completion of its 2025 Second Share Repurchase Plan, which involved repurchasing and canceling A shares to safeguard company value and shareholder interests. The plan, which utilized RMB1 billion in funds, was executed without deviation from its original disclosure and will not materially impact the company’s operations, financials, or listing status.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Completes HK$1.5 Billion H Share Acquisition for Employee Incentive Scheme

WuXi AppTec Co., Ltd. announced the completion of the acquisition of H Shares worth HK$1.5 billion under the 2025 H Share Award and Trust Scheme. This acquisition, which represents approximately 0.73% of the company’s total issued share capital, aims to incentivize core employees by granting them Award Shares upon meeting specific revenue targets. The move is part of WuXi AppTec’s strategy to align employee interests with company performance, although there remains uncertainty about meeting the revenue conditions required for the grant.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Adjusts Conversion Price of Convertible Bonds

WuXi AppTec Co., Ltd. announced an adjustment to the conversion price of its $500 million zero coupon guaranteed convertible bonds due 2025. The conversion price has been adjusted from HK$80.02 to HK$78.28 per H Share following the approval of the 2024 Profit Distribution and the 2025 Special Dividend Distribution. This adjustment will result in an increase in the number of H Shares issuable upon full conversion of the bonds, enhancing the company’s share capital and potentially impacting its market positioning.

The most recent analyst rating on (HK:2359) stock is a Buy with a HK$50.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Announces Grant of H Share Awards Under 2024 Scheme

WuXi AppTec Co., Ltd. has announced the grant of 27,274,870 H Share Awards under its 2024 H Share Award and Trust Scheme to 3,985 selected participants. This grant, representing approximately 7.0464% of the total issued H Shares, is aimed at incentivizing both connected and independent participants, without causing any dilution effect on existing shareholders. The board considers this grant to be fair and in the best interest of the company and its shareholders.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

WuXi AppTec Adjusts Share Repurchase Price Limits Amid Dividend Distributions

WuXi AppTec Co., Ltd. announced adjustments to the upper limit of the price for its A Share repurchase plans following the implementation of its 2024 Profit Distribution and 2025 Special Dividend Distribution. The company plans to repurchase A Shares through two separate plans in 2025, each with a budget of RMB1 billion, aiming to cancel and reduce registered capital. The adjustments in the share repurchase price limits are in response to the company’s dividend distributions, ensuring compliance with relevant regulations. This move is expected to impact the company’s capital structure and provide returns to shareholders.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.